Intrexon | XON - PE Price to Earnings


Intrexon reported 7.54 in PE Price to Earnings for its fiscal quarter ending in December of 2021.





Pe Change Date
Amgen 18.07 1.77 Jun/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Arrowhead Research 39.19 0 Jun/2026
AstraZeneca 25.34 4.25 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Incyte 14.45 0.9 Jun/2026
Intrexon 7.54 221.44 Dec/2021
Ligand Pharmaceuticals 84.31 27.81 Jun/2026
MannKind 201.15 102.55 Mar/2026
Merck 32.26 15.74 Jun/2026
Novartis 22.41 2.24 Jun/2026
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Roche Holding 16.48 0.39 Jun/2026
Thermo Fisher Scientific 26.4 1.31 Jun/2026
Veracyte 42.77 17.88 Jun/2026
Xencor 29.92 3.22 Sep/2022